Intravitreal injection versus sub-tenon S infusion of triamcinolone acetonide during cataract surgery in patients with refractory diabetic macular edema (2010)
- Authors:
- USP affiliated authors: MESSIAS, ANDRÉ MÁRCIO VIEIRA - FMRP ; JORGE, RODRIGO - FMRP
- Unidade: FMRP
- Subjects: DIABETES MELLITUS; EDEMA MACULAR CISTOIDE; CATARATA (CIRURGIA)
- Language: Inglês
- Imprenta:
- Source:
- Título: Abstracts
- Conference titles: Congresso da Sociedade Brasileira de Retina e Vítreo
-
ABNT
TAKATA, Clécio et al. Intravitreal injection versus sub-tenon S infusion of triamcinolone acetonide during cataract surgery in patients with refractory diabetic macular edema. 2010, Anais.. São Paulo: SBRV, 2010. . Acesso em: 20 out. 2024. -
APA
Takata, C., Messias, A. M. V., Folgosa, M. S., Lucena, L. R., Lucena, D. R., & Jorge, R. (2010). Intravitreal injection versus sub-tenon S infusion of triamcinolone acetonide during cataract surgery in patients with refractory diabetic macular edema. In Abstracts. São Paulo: SBRV. -
NLM
Takata C, Messias AMV, Folgosa MS, Lucena LR, Lucena DR, Jorge R. Intravitreal injection versus sub-tenon S infusion of triamcinolone acetonide during cataract surgery in patients with refractory diabetic macular edema. Abstracts. 2010 ;[citado 2024 out. 20 ] -
Vancouver
Takata C, Messias AMV, Folgosa MS, Lucena LR, Lucena DR, Jorge R. Intravitreal injection versus sub-tenon S infusion of triamcinolone acetonide during cataract surgery in patients with refractory diabetic macular edema. Abstracts. 2010 ;[citado 2024 out. 20 ] - Ranibizumabe intravítreo no pré-operatório de vitrectomia em pacientes diabéticos com descolamento de retina tracional
- Diabetic macular edema treatment with bevacizumab vs. ranibizumab: a microperimetry study
- Intravitreal bevacizumab or triamcinolone combined with macular laser photocoagulation for diabetic macular edema: preliminary results
- Intravitreal ranibizumab for persistent new vessels in diabetic retinopathy
- Quality of life in patients with retinitis pigmentosa undergoing treatment with intravitreal bone marrow-derived stem cells (Reticell -clinical trial)
- ERG findings after one year intravitreal ranibizumab and single or multiple spot panphotocoagulation treatment for proliferative diabetic retinopathy
- Changes in retinal function and structure following intravitreal anti-vascular endothelial growth factor (anti-VEGF) treatment for diabetic macular edema
- Intravitreal autologous bone marrow derived stem cells in ischemic macular edema: results after 6 months follow-up
- Dark-adapted b-wave luminance function: comparison of two mathematical models in normal subjects and in patients with retinal dystrophy
- Macular laser photocoagulation combined with intravitreal bevacizumab or triamcinolone for diabetic macular edema
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
